Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografische gegevens
Hoofdauteur:	Alim, Abdul
Andere auteurs:	Yasmin, Professor Dr. Hasina
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	Brac University 2023
Onderwerpen:	Alzheimer’s disease Rivastigmine
Online toegang:	http://hdl.handle.net/10361/18748

Gelijkaardige items

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
door: Shehab, Habibul Mohsin
Gepubliceerd in: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
door: Mahee, Sadique Abdal
Gepubliceerd in: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
door: Chowdhury, Sariya Uzrat
Gepubliceerd in: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
door: Tabassum, Nadira
Gepubliceerd in: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
door: Islam, Md. Irfath
Gepubliceerd in: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
door: Saha, Bithi Rani
Gepubliceerd in: (2023)

Alzheimer's disease and marriage : an intimate account /
door: Wright, Lore K.
Gepubliceerd in: (1993)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
door: Ishrat, Nowshin
Gepubliceerd in: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
door: Hassan, Md. Muhtaz
Gepubliceerd in: (2020)

Emerging therapies of Alzheimer’s disease: a comprehensive review
door: Tasin, Md Abtahi
Gepubliceerd in: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
door: Aziz, Farhin
Gepubliceerd in: (2019)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
door: Karmaker, Swastika
Gepubliceerd in: (2024)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
door: Tamanna, Mst. Taskia
Gepubliceerd in: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
door: Tasneem, Sadia
Gepubliceerd in: (2021)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
door: Afra, Sumaiya
Gepubliceerd in: (2022)

Marine compounds in the treatment of Alzheimer’s disease
door: Parveen, Sanjana
Gepubliceerd in: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
door: Halim, Rabea
Gepubliceerd in: (2022)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
door: Haque, Mushfiqul
Gepubliceerd in: (2019)

Exploring Alzheimer's disease prediction with XAI in various neural network models
door: Rahman, Quazi Ashikur, et al.
Gepubliceerd in: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
door: Aana, Afsara Sumon
Gepubliceerd in: (2021)

A review on adult neurogenesis in Alzheimer’s disease
door: Akter, Moriam
Gepubliceerd in: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
door: Mostofa, Golam
Gepubliceerd in: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
door: Zaman, Rubaiyat
Gepubliceerd in: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
door: Bakar, Osama Bin Abu
Gepubliceerd in: (2024)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
door: Roy, Aditya, et al.
Gepubliceerd in: (2023)

An ambient assisted living system for Alzheimer’s patients
door: Abedin, Minhajul, et al.
Gepubliceerd in: (2023)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
door: Jahan, Nusrat
Gepubliceerd in: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
door: Dey, Manashi
Gepubliceerd in: (2024)

Role of circular RNA in neurological disease
door: Salsabil, Labiba
Gepubliceerd in: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
door: Sani, Mehedi Hasan, et al.
Gepubliceerd in: (2022)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
door: Mahbub, Riasat, et al.
Gepubliceerd in: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
door: Alam, Badrul, et al.
Gepubliceerd in: (2016)

Gene editing for neurodegenerative diseases-A review
door: Sharna, Anika Islam
Gepubliceerd in: (2023)

Skeleton /
door: Parkin, Peter

Detection of alzheimer's disease using deep learning
door: Hasan, Mahmudul, et al.
Gepubliceerd in: (2021)

Early prediction of Alzheimer's disease using convolutional neural network
door: Abed, Mahjabeen Tamanna, et al.
Gepubliceerd in: (2020)

Multi-classification based Alzheimer's disease detection with comparative analysis from brain MRI scans using deep learning
door: Kabir, Azmain, et al.
Gepubliceerd in: (2022)

Detecting different stages of Alzheimer’s disease from MRI images using deep learning and computer vision techniques
door: Rahman, Fardin, et al.
Gepubliceerd in: (2024)

Recall-Net: A CNN-based Model for Four-class Classification of Alzheimer’s Disease
door: Hasan, M. M. Kamrul, et al.
Gepubliceerd in: (2022)

Alzheimer’s Disease detection and classification using transfer learning techniques and ensembling operations on convolutional neural networks
door: Awwal, Alvina, et al.
Gepubliceerd in: (2021)